THRX - Theseus Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Theseus Pharmaceuticals's activity chart (see below) currently has 18 price targets and 19 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 12.5% with an average time for these price targets to be met of 277.5 days.

Most recent stock forecast was given by ALETHIA YOUNG from CANTOR FITZGERALD on 14-Jul-2023. First documented stock forecast 09-Sep-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 30-Jun-2022

$9

$4.94 (121.67%)

$22

Show more analysts

Please expand the browser size to see the chart

What is THRX (Theseus Pharmaceuticals) average time for price targets to be met?

On average it took 277.5 days on average for the stock forecasts to be realized with a an average price target met ratio 12.5

Which analyst has the current highest performing score on THRX (Theseus Pharmaceuticals) with a proven track record?

AMI FADIA

Which analyst has the current lower performing score on THRX (Theseus Pharmaceuticals) with a proven track record?

BRIAN SKORNEY

Which analyst has the most public recommendations on THRX (Theseus Pharmaceuticals)?

Ami Fadia works at NEEDHAM and has 21 price targets and 12 ratings on THRX

Which analyst is the currently most bullish on THRX (Theseus Pharmaceuticals)?

Andrew Berens with highest potential upside - $23.95

Which analyst is the currently most reserved on THRX (Theseus Pharmaceuticals)?

Ami Fadia with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?